Skip to content

Public FDA record

Z-1043-2023: (1) Vanguard Knee System PS Open Box Femoral; Left; 57.5 mm. Intended for Knee joint replacement prosthes

Recall record Z-1043-2023 for Biomet, Inc.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1043-2023
Company in FDA record
Biomet, Inc.
FDA classification date
Jan 30, 2023
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Components Incorrectly labeled as either smaller or larger and incorrect side (right/left).

Source facts

Action
UPDATE: 2/7/23 Zimmer Biomet issued URGENT MEDICAL DEVICE RECALL EXPANSION Letter on 2/07/23 to Distributors, Risk Manager, Surgeons. (An Urgent Medical Device Letter issued to consignees new accounts not previously notified Dec 29, 2022). Letters state reason for recall, health risk and action to take: This is a 14-lot scope expansion to the recall notification initiated on December 29, 2022, for the Vanguard Posterior Stabilized Open Box Femoral components. Letter states reason for recall, health risk and action to take: . Immediately locate and quarantine affected product in your inventory. Return all affected product from your distributorship and from affected hospitals within your territory. . Complete Inventory Return Certification Form for each return and send to CorporateQuality.PostMarket@zimmerbiomet.com, even if you do not have affected products available to return in your territory. . If you have further questions or concerns after reviewing this notice, please call customer service at 574-371-3071 between 8:00 am and 5:00pm EST, Monday through Friday. Or your questions may be emailed to CorporateQuality.PostMarket@zimmerbiomet.com. ______________________________________________________________________ Zimmer Biomet issued Urgent Medical Device Recall via email on December 29, 2022. OUS Distributors notified via email. Hospital risk managers and surgeons, as well as distributors with product notified via courier. Surgeons will be provided with a letter that identifies the issue and their responsibilities, which include: - Following any specified patient monitoring instructions. - Returning Certificate of Acknowledgment to Zimmer Biomet.
Initiated
2022-12-29
Root cause
Labeling Change Control
Distribution
International distribution to the countries of: Argentina, China, Costa Rica, India, Japan, Mexico, Netherlands, Ecuador, Republic of Korea, Singapore, and Thailand. Expanded Recall US states of: FL, IN, MD, OH, PA, WI
Recall number
Z-1043-2023
Recall status
Open, Classified
CDRH record ID
198032
FDA classified
2023-01-30
Recall event number
91489

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗